Active site-directed double mutants of dihydrofolate reductase Journal Article


Authors: Ercikan-Abali, E. A.; Mineishi, S.; Tong, Y.; Nakahara, S.; Waltham, M. C.; Banerjee, D.; Chen, W.; Sadelain, M.; Bertino, J. R.
Article Title: Active site-directed double mutants of dihydrofolate reductase
Abstract: Variants of dihydrofolate reductase (DHFR), which confer resistance to antifulates, are used as dominant selectable markers in vitro and in vivo and may be useful in the context of gene therapy. To identify improved mutant human DHFRs with increased catalytic efficiency and decreased binding to methotrexate, we constructed by site-directed mutagenesis four variants with substitutions at both Leu22 and Phe31 (i.e., Phe22-Ser31, Tyr22- Ser31, Phe22-Gly31, and Tyr22-Gly31). Antifolate resistance has been observed previously when individual changes are made at these active- site residues. Substrate and antifolate binding properties of these 'double' mutants revealed that each have greatly diminished affinity for antifolates (> 10,000-fold) yet only slightly reduced substrate affinity. Comparison of in vitro measured properties with those of single-residue variants indicates that double mutants are indeed significantly superior. This was verified fur one of the double mutants that provided high-level methotrexate resistance following retrovirus-mediated gene transfer in NIH3T3 cells.
Keywords: methotrexate; polymerase chain reaction; animals; mice; amino acid substitution; enzyme activity; structure activity relation; tyrosine; gene transfer; cancer resistance; kinetics; recombinant proteins; substrate specificity; gene therapy; mutagenesis, site-directed; binding sites; catalysis; point mutation; dihydrofolate reductase; folic acid antagonist; folic acid antagonists; tetrahydrofolate dehydrogenase; site directed mutagenesis; drug binding; phenylalanine; 3t3 cells; variation (genetics); humans; human; priority journal; article
Journal Title: Cancer Research
Volume: 56
Issue: 18
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 1996-09-15
Start Page: 4142
End Page: 4145
Language: English
PUBMED: 8797582
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Citation Impact
MSK Authors
  1. Debabrata Banerjee
    136 Banerjee
  2. Joseph Bertino
    363 Bertino
  3. Michel W J Sadelain
    587 Sadelain
  4. Emine A Ercikan
    23 Ercikan
  5. Mark C. Waltham
    23 Waltham